These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

929 related items for PubMed ID: 25926473

  • 21. How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey.
    Bongiorni MG, Marinskis G, Lip GY, Svendsen JH, Dobreanu D, Blomström-Lundqvist C, Scientific Initiative Committee, European Heart Rhythm Association.
    Europace; 2012 Nov; 14(11):1666-9. PubMed ID: 23104858
    [Abstract] [Full Text] [Related]

  • 22. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
    Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, Preminger M, Sichrovsky T, Steinberg JS.
    Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
    [Abstract] [Full Text] [Related]

  • 23. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
    Wilkoff BL, Boriani G, Mittal S, Poole JE, Kennergren C, Corey GR, Krahn AD, Schloss EJ, Gallastegui JL, Pickett RA, Evonich RF, Roark SF, Sorrentino DM, Sholevar DP, Cronin EM, Berman BJ, Riggio DW, Khan HH, Silver MT, Collier J, Eldadah Z, Holbrook R, Lande JD, Lexcen DR, Seshadri S, Tarakji KG.
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008503. PubMed ID: 32915063
    [Abstract] [Full Text] [Related]

  • 24. Mortality and cost associated with cardiovascular implantable electronic device infections.
    Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ.
    Arch Intern Med; 2011 Nov 14; 171(20):1821-8. PubMed ID: 21911623
    [Abstract] [Full Text] [Related]

  • 25. Low lateral thoracic site for cardiac implantable electronic device implantation: A viable alternative in patients with limited access options after infected device extraction.
    Liang JJ, Schaller RD, Modi DS, Enriquez A, Supple GE, Cooper JM.
    Heart Rhythm; 2017 Oct 14; 14(10):1506-1514. PubMed ID: 28603001
    [Abstract] [Full Text] [Related]

  • 26. Redo procedures and chronic renal dysfunction are associated with higher risk of cardiac electronic device infections.
    Morani G, Mugnai G, Bolzan B, Morosato M, Tomasi L, Ferrari S, Vassanelli C.
    Minerva Cardioangiol; 2018 Jun 14; 66(3):225-232. PubMed ID: 29308851
    [Abstract] [Full Text] [Related]

  • 27. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association.
    Traykov V, Bongiorni MG, Boriani G, Burri H, Costa R, Dagres N, Deharo JC, Epstein LM, Erba PA, Snygg-Martin U, Nielsen JC, Poole JE, Saghy L, Starck C, Strathmore N, Blomström-Lundqvist C.
    Europace; 2019 Aug 01; 21(8):1270-1279. PubMed ID: 31209483
    [Abstract] [Full Text] [Related]

  • 28. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
    Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, Gallastegui J, Pickett RA, Evonich R, Philippon F, McComb JM, Roark SF, Sorrentino D, Sholevar D, Cronin E, Berman B, Riggio D, Biffi M, Khan H, Silver MT, Collier J, Eldadah Z, Wright DJ, Lande JD, Lexcen DR, Cheng A, Wilkoff BL, WRAP-IT Investigators.
    N Engl J Med; 2019 May 16; 380(20):1895-1905. PubMed ID: 30883056
    [Abstract] [Full Text] [Related]

  • 29. REPLACE DARE (Death After Replacement Evaluation) score: determinants of all-cause mortality after implantable device replacement or upgrade from the REPLACE registry.
    Chung MK, Holcomb RG, Mittal S, Steinberg JS, Gleva MJ, Mela T, Uslan DZ, Mitchell K, Poole JE, REPLACE Investigators.
    Circ Arrhythm Electrophysiol; 2014 Dec 16; 7(6):1048-56. PubMed ID: 25221331
    [Abstract] [Full Text] [Related]

  • 30. The never-ending story of CIED infection prevention: Shall we WRAP-IT and go?
    Biffi M.
    J Cardiovasc Electrophysiol; 2019 Aug 16; 30(8):1191-1196. PubMed ID: 31172637
    [Abstract] [Full Text] [Related]

  • 31. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M, Henrikson CA, Jo Braid-Forbes M, Forbes KF, Lerner DJ.
    Pacing Clin Electrophysiol; 2015 Feb 16; 38(2):231-9. PubMed ID: 25243484
    [Abstract] [Full Text] [Related]

  • 32. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).
    Sohail MR, Palraj BR, Khalid S, Uslan DZ, Al-Saffar F, Friedman PA, Hayes DL, Lohse CM, Wilson WR, Steckelberg JM, Baddour LM.
    Circ Arrhythm Electrophysiol; 2015 Feb 16; 8(1):137-44. PubMed ID: 25504648
    [Abstract] [Full Text] [Related]

  • 33. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M, Gadula-Gacek E, Kurek A, Adamowicz-Czoch E, Olszowski D, Ostręga M, Ciślak A, Pyka Ł, Hawranek M, Lekston A, Poloński L, Gąsior M.
    Cardiol J; 2017 Feb 16; 24(5):515-522. PubMed ID: 27734455
    [Abstract] [Full Text] [Related]

  • 34. New Insights into Predictors of Cardiac Implantable Electronic Device Infection.
    Sadeghi H, Alizadehdiz A, Fazelifar A, Emkanjoo Z, Haghjoo M.
    Tex Heart Inst J; 2018 Jun 16; 45(3):128-135. PubMed ID: 30072848
    [Abstract] [Full Text] [Related]

  • 35. Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.
    Koneru JN, Jones PW, Hammill EF, Wold N, Ellenbogen KA.
    J Am Heart Assoc; 2018 May 10; 7(10):. PubMed ID: 29748177
    [Abstract] [Full Text] [Related]

  • 36. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A, Kutarski A, Czekajska-Chehab E, Adamczyk P, Boczar K, Polewczyk M, Janion M.
    Cardiol J; 2014 May 10; 21(2):128-37. PubMed ID: 24526508
    [Abstract] [Full Text] [Related]

  • 37. Strategies to prevent infections associated with cardiovascular implantable electronic devices.
    Palraj BR, Farid S, Sohail MR.
    Expert Rev Med Devices; 2017 May 10; 14(5):371-381. PubMed ID: 28434261
    [Abstract] [Full Text] [Related]

  • 38. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
    Koerber SM, Turagam MK, Winterfield J, Gautam S, Gold MR.
    J Cardiovasc Electrophysiol; 2018 Apr 10; 29(4):609-615. PubMed ID: 29364546
    [Abstract] [Full Text] [Related]

  • 39. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM, Wang X, Krahn AD, Morillo CA, Connolly SJ, Healey JS.
    J Cardiovasc Electrophysiol; 2010 Jul 10; 21(7):786-90. PubMed ID: 20102431
    [Abstract] [Full Text] [Related]

  • 40. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
    Malagù M, Vitali F, Brieda A, Cimaglia P, De Raffele M, Tazzari E, Musolino C, Balla C, Serenelli M, Cultrera R, Rapezzi C, Bertini M.
    Europace; 2022 Mar 02; 24(3):413-420. PubMed ID: 34487163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.